Abstract
Interleukin-1α (IL-1α) is one of the most potent bone-resorbing factors involved in the bone loss that is associated with inflammation. We examined the effect of the inflammatory mediator IL-1α on the expression of macrophage colony-stimulating factor (M-CSF), osteoprotegerin (OPG), and prostaglandin E 2 (PGE 2) in rat osteoblasts, and the indirect effect of IL-1α on the formation of osteoclast-like cells. Osteoblasts were cultured in α–minimum essential medium containing 10% fetal bovine serum with or without 100 units/ml of IL-1α for up to 14 days. The gene and protein expression of M-CSF and OPG were estimated by determining mRNA levels using the real-time polymerase chain reaction and protein levels using Western blot analysis. PGE 2 expression was determined using an enzyme-linked immunosorbent assay. The formation of osteoclast-like cells was estimated using tartrate-resistant acid phosphatase (TRAP) staining of osteoclast precursors in culture with conditioned medium from IL-1α-treated osteoblasts and the soluble receptor activator of NF-κB ligand (RANKL). M-CSF and PGE 2 expression in osteoblasts increased markedly in cells cultured with IL-1α, whereas OPG expression decreased. The conditioned medium containing M-CSF and PGE 2 produced by IL-1α-treated osteoblasts and soluble RANKL increased the TRAP staining of osteoclast precursors. These results suggest that IL-1α stimulated the formation of osteoclast-like cells via an increase in M-CSF and PGE 2 production, and a decrease in OPG production by osteoblasts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.